ArticleInternational journal of cancer2016
Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.
Article in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
166 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Outcomes of the management of synchronous rectal and prostate cancer: a systematic review.International journal of colorectal disease · 2025Pooled it
- Survival Rate and Prognostic Factors of Localised Prostate Cancer in Southeast Asian Countries: A Systematic Review with Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2023Pooled it
- Prognostic impact of geriatric nutritional risk index on patients with urological cancers: A meta-analysis.Frontiers in oncology · 2022Pooled it
- Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis.Cancer medicine · 2020Pooled it
- Prediction models for prostate cancer to be used in the primary care setting: a systematic review.BMJ open · 2020Pooled it
- Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis.Annals of global health · 2020Pooled it
- Machine learning analysis for the noninvasive prediction of lymphovascular invasion in gastric cancer using PET/CT and enhanced CT-based radiomics and clinical variables.Abdominal radiology (New York) · 2022Trial
- Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998-2017.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021Trial
- Trial
- Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?BioMed research international · 2017Trial
- Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Asian journal of andrologyTrial
- Radical prostatectomy without prior biopsy: an initial decision-making algorithm based on PSMA PET/mpMRI.Prostate cancer and prostatic diseases · 2026Article
- Global burden of prostate cancer (1990-2021) from Brazil: trends in disability-adjusted life years, incidence, mortality, and prevalence.Cancer causes & control : CCC · 2026Article
- Development and interpretability of a machine learning-derived model for the identification of latent prostate cancer in patients initially diagnosed with benign prostatic hyperplasia: a retrospective cohort study.BMC medical informatics and decision making · 2026Article
- Diagnostic performance of magnetic resonance imaging-targeted biopsy for PI-RADS ≥3 peripheral zone lesions in multiparametric prostate magnetic resonance imaging: correlation with clinically significant prostate cancer.Diagnostic and interventional radiology (Ankara, Turkey) · 2026Article
- Impact of repeated prostate-specific antigen testing on management patterns and personal healthcare spending for prostate cancer: A population-based study National Health Insurance data for 166,848 patients in South Korea from 2010 to 2020.Investigative and clinical urology · 2026Article
- Urine-Based Machine Learning Assay Detects Prostate Cancer.Diagnostics (Basel, Switzerland) · 2026Article
- Global, regional, and national burden of early-onset prostate cancer, 1990-2021: a systematic analysis for the global burden of disease study 2021.World journal of surgical oncology · 2026Article
- Burden of prostate cancer in older adults, 1990-2021: a systematic analysis based on the global burden of disease study 2021.BMC geriatrics · 2026Article
- Association between family history and onset age of cancer in China.Chinese medical journal · 2026Article
106 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Prostate cancer is a significant public health burden and a major cause of morbidity and mortality among men worldwide. Analyzing geographic patterns and temporal trends may help identify high-risk populations, suggest the degree of PSA testing, and provide clues to etiology. We used incidence data available from the International Agency for Research on Cancer (IARC) and certain cancer registries for 43 populations across five continents during a median period of 24 years. Trends in overall prostate cancer rates showed five distinct patterns ranging from generally monotonic increases to peaking of rates followed by declines, which coincide somewhat with changes in the prevalence of PSA testing. Trends in age-specific rates generally mirrored those in the overall rates, with several notable exceptions. For populations where overall rates increased rapidly and then peaked, exemplified in North America and Oceania, the highest incidence tended to be most pronounced and occurred during earlier calendar years among older men compared with younger ones. For populations with almost continual increases in overall rates, exemplified in Eastern Europe and Asia, peaks were evident among men aged ≥ 75 years in many instances. Rates for ages 45-54 years did not clearly stabilize or decline in the majority of studied populations. Global geographic variation remained substantial for both overall and age-specific incidence rates regardless of levels of PSA testing, with the lowest rates consistently in Asia. Explanations for the persistent geographic differences and the continuing increases of especially early-onset prostate cancer remain unclear.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.